Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Randomized study in 2 arms, without any masking in patients with non small cell lung cancer,
histologically or cytologically confirmed, not liable to surgery, stage IIIB or IIIA,
according to the TNM classification of the American Joint Committee for cancer. In one arm
will be administered concomitant radiotherapy and carboplatin-docetaxel-gemcitabine followed
by docetaxel and, in the other arm will be administered docetaxel-gemcitabine followed by
concurrent radiotherapy with carboplatin-docetaxel